ESP's fiscal Q4 earnings rise year over year, but sales witnessed a dip. Strong backlog and new orders highlight demand momentum despite quarterly revenue softness.
Zacks·1mo ago
More News
The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey
Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects.
Zacks·2mo ago
Top Analyst Reports for Merck, Palo Alto & Freeport
Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand.
Zacks·2mo ago
Top Analyst Reports for Mastercard, Verizon & Stryker
Zacks·5mo ago
Unite Group makes revised bid to buy Empiric in cash-and-stock deal; stock up 6%
investing.com·5mo ago
Espey Stock Gains 16% on Q3 Earnings Up Y/Y, Backlog Hits $138 Million